This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
In this month’s update, Dr. Tracy Pfeifer highlights all our webinars, like Master Class and AlliedPro Forum, all the travels from New York to Florida, recapping the Facial and Rhinoplasty Symposium and the upcoming The MEET 2026 in Boston!
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
In this month’s update, Dr. Tracy Pfeifer highlights the importance of fellowships and residents, how AlliedPro can help evolve staff's education, The Aesthetic Cruise 2026 is almost sold out, and the upcoming Facial and Rhinoplasty Symposium!
We did it!! 🎉
The Aesthetic Surgery Journal now holds the highest Impact Factor in plastic surgery 3.9! This catapults ASJ into first place in our specialty (both plastic and aesthetic surgery) for the first time!